Login / Signup

An overview of the efficacy and safety of β 2 -adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease.

Maria Gabriella MateraPaola RoglianiLuigino CalzettaMario Cazzola
Published in: Expert opinion on drug safety (2024)
-ARs, has garnered interest and debate, but further research efforts should focus on elucidating the optimal use of β-AR antagonists in COPD, balancing cardiovascular benefits with potential respiratory risks to enhance outcomes and quality of life for individuals living with this debilitating respiratory condition.
Keyphrases
  • human health
  • chronic obstructive pulmonary disease
  • lung function
  • respiratory tract
  • type diabetes
  • risk assessment
  • metabolic syndrome
  • climate change
  • skeletal muscle
  • weight loss